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Catheter-related Infections Complicating Central Venous Catheter Access Device Insertion: A Retrospective Audit and Comparison of Two Cohorts
Background. Central venous access devices (CVAD) are essential for long-term intra-venous treatment of malignancies and other conditions. Catheter-related infections (CRI) complicate long-term CVAD use at rates between 1.5 and 5%, resulting in significant morbidity and mortality. Current evidence does not support a role for antibiotic prophylaxis pre-insertion. We aim to determine rates of CRIs complicating CVAD insertions by vascular surgery and interventional radiology in a single institution and examine the role of antibiotic prophylaxis in prevention.
Methods. A retrospective audit was carried out on CVAD insertions (tunnelled central venous catheter (CVC) or subcutaneous port) by the Vascular Surgery and Radiology Departments at a tertiary teaching hospital in Sydney, Australia from January 2014 to December 2016. Data were collected on patient demographics, antibiotic prophylaxis, skin preparation and CRIs. Rates of CRIs were compared by chisquare test (α 0.05).
Results. Ninety-five (11 tunnelled CVC; 84 subcutaneous ports) and 222 (21 tunnelled CVC; 201 subcutaneous ports) CVAD insertions were performed by vascular surgery and radiology, respectively. Median age was 56 years in the vascular cohort and 64 years in the radiology cohort. Females were predominant in both vascular (70; 73.7%) and radiology (119, 53.6%) cohorts and the most common indication was chemotherapy (vascular 84; 88.4% and radiology 205; 92.8%, n = 1 missing). Antibiotic prophylaxis was used in 88 (92.6%) vascular insertions but only 2 (0.95%, n = 12 missing) insertions by radiology. Iodine skin preparation was preferred for vascular insertions (92; 98.9%, n = 2 missing) compared with chlorhexidine for radiology insertions (214; 97.7%, n = 3 missing). CRIs occurred in 4 (4.2%) of the vascular cohort and 8 (3.6%) of radiology cohort (P = 0.80).
Conclusion. Rates of CRIs complicating CVAD procedures were similar in a vascular cohort where most received antibiotic prophylaxis, and in a radiology cohort where antibiotic prophylaxis was rarely used. There was no evidence to support antibiotic prophylaxis in prevention of CRIs, although choice of skin preparation and other factors may have confounded findings.
Disclosures. Background. Although PICCs are important for venous access, they pose risk of infection, venous thrombosis, and are costlier relative to other forms of vascular access. We conducted a preliminary quality improvement study to assess the indications for PICC placement at our institution and also to evaluate the associated healthcare cost.
Methods. We obtained data on all PICCs placed by the vascular access team over a representative 2-month period (November and December 2017) at Allegheny General Hospital. Indications entered during order entry for PICC placement were collected. Additionally, charts of all central line-associated blood stream infections (CLABSI) in 2017 were reviewed to determine the number of events where PICC may have been implicated. We calculated the cost incurred for PICC placement and that for treating infection in PICC-associated CLABSI. The cost of each PICC insertion is about $4,700 and that of each CLABSI approximates $25,000.
Results. A total of 451 PICCs were inserted over the 2-month period. Documented indications for PICC insertion included: "poor venous access" (128, 28.3%), "receiving high-risk drugs" (91, 20%), "requires multiple simultaneous IV infusions" (84, 18.6%), "needed upon discharge for long-term use" (63, 13.9%), and "receiving vasopressors, total parental nutrition or chemotherapy" (61, 13.6%). There was no indication described for 23 PICC orders (5.2%). Twenty-five CLABSI were encountered in 2017; 10 of them were PICC associated. Of those, PICC was not absolutely indicated in two patients based on chart review (with cost burden of about $65,000 in these two instances).
Conclusion. Poor venous access and multiple IV infusions are not absolute indications for PICC insertion in most circumstances. In our study, this amounted to nearly half (212/451) of the indications for PICC placement. Our hospital could have potentially saved a million dollars in the 2-month study period if PICCs were not placed for these indications. Given the costs and risks associated with PICC use, alternative venous access devices should be strongly considered. By rigorously reevaluating indications for PICC use we may improve both patient outcomes and reduce healthcare costs.
Disclosures. All authors: No reported disclosures. Background. Burkholderia cepacia complex (Bcc) is Gram-negative bacteria commonly affecting those with cystic fibrosis, causing pneumonia and also a nosocomial pathogen. We looked at the clinical profile and possible source of Bcc bacteremia in patients without cystic fibrosis, admitted to a tertiary care hospital in South India.
Clinical Profile of Patients with
Methods. Retrospective chart review was done of patients with Bcc bacteremia over the period 2012-2017. Patient risk factors, outcome, sensitivity profile were looked into. Possible sources for Bcc were analysed.
Results. Twenty-two patients with Bcc bacteremia were identified during this period. Age of patients ranged from 16 months to 83 years, averaging 47 years. 89.5% were nosocomial; 77.3% had indwelling vascular catheter, either CVC, dialysis catheter or permacath. When 30 days mortality was looked at, 17 patients survived and five patients expired. Those who expired had high Pitt's bacteremic score (scoring done either prior to or within 48 hours of positive culture). Four patients had underlying pneumonia, among whom two patient's respiratory sample grew Bcc, three also had underling vascular catheters. Sensitivity pattern of Bcc was noted as follows-trimethoprim sulfamethoxazole was uniformly sensitive (100%), ceftazidime was sensitive in 86.5%, minocycline in 73% of isolates. Meropenem was tested in 19 and was found sensitive in 15 isolates (79%), fluoroquinolone was tested only in eight isolates and was sensitive in 7.
As majority was CLABSI, the bundle compliance and common products used for cvc were audited. Feedback and training for bundle compliance were given. The ultrasound gel, even the unopened bottle used for cvc insertion grew Bcc. Despite sterile cover around the probe after the application of contaminated gel, an associated risk was considered and was replaced with sterile gel sachet. At 3 months follow-up there is no further incidence of Bcc bacteremia, though longer follow-up is needed.
Conclusion. Bcc bacteremia is found to be an important nosocomial pathogen, commonly associated with intravascular catheters with 22.7% mortality in this study. Cotrimoxazole was 100% sensitive. Good infection control practices, including early removal of unnecessary catheters are important to prevent Bcc CLABSI. Ultra sound gels can harbour Bcc and poses a serious risk of infection.
Disclosures. All authors: No reported disclosures. Background. Proven measures to prevent VAP include 35-45¡ inclination of the head, prompt extubation, hand hygiene prior to intubation, oral hygiene with clorhexidine, minimize secretion pooling above the endothraqueal tube cuff. Adherence to these methods remains an angular point in preventing VAP's. Increasing rates of VAP in the pediatric critical care unit (PICU) of a reference teaching hospital in Guatemala, led the Hospital Infection Prevention and Control (HIPC) team to implement a bundle to control VAP's.
Impact of a Supervision and Education Directed Bundle in Ventilator-
Methods. A daily active surveillance to identify cases of VAP according to the Center for Disease Control (CDC) definition was done for 10 months before the HIPC intervention. The HAI implemented a bundle defined as: (1) head elevation (35¡ degree inclination), (2) hand hygiene, (3) oral hygiene with clorhexidine, (4) minimize secretion pooling, (5) daily evaluation of extubation, (6) daily surveillance, (7) continuous education of personnel, (8) adequate supplies distribution analysis. After the intervention rates and trends of VAP where analyzed for 30 months.
Results. In the pre-intervention observational period the rates of VAP increased from 18 (September 2014) to 28 cases per 1,000 ventilator-days (June 2015). The first month after the bundle implementation (July 2015) a 50% VAP rate decreased was evidenced. A constant decrease in VAP rates was reported in the 24 months after the implementation of the bundle, reaching the lowest rate in August 2017 (five cases per 1,000 ventilator-days). For administrative reasons adherence to oral hygiene with clorhexidine was sub-optimal due to a lack of supplies from August 2017 to December 2017 which coincided with an increase in VAP rates from five to 14 per cases 1,000 ventilator-days.
Conclusion. A notable and constant reduction of VAP rates in the PICU was achieved after the implementation of the bundle. Even though many of the measures included in the bundle were already protocoled in the PICU, a probable lack of adherence could explain the high rates observed pre-intervention. By adding the continuous education and supervision of the personnel by a member of the HIPC team, to previously proven methods, the VAP rates decreased in almost 80%. This makes a strong case for the idea that protocols without continuous enforcement might not be enough to control infections.
Disclosures. 
